Search
for
Sort by
Research 121–150 of 877
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Generation and characterization of rat liver stem cell lines and their engraftment in a rat model of liver failure
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- TOXIC EPIDERMAL NECROLYSIS
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- A preliminary study of finasteride in Tourette syndrome
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Involvement of scalp and nails in lupus erythematosus
- Acquired scalp alopecia. Part I: A review
- Mitoxantrone
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Hair growth promoting activity of cedrol isolated from the leaves of Platycladus orientalis
- Hair loss and herbs for treatment
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- p53‐dependent transcriptional regulation of EDA2R and its involvement in chemotherapy‐induced hair loss
- Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study
- Acquired scalp alopecia. Part II: A review
- Regulation of VDR by ΔNp63α is associated with inhibition of cell invasion
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- Hair loss in elderly women
- Alopecia neoplastica simulating alopecia areata and antedating the detection of primary breast carcinoma
- Parkinson's disease and skin
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Sp6 downregulation of follistatin gene expression in ameloblasts
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Skin manifestations among<i>GATA2</i>-deficient patients